CNBC Markets Now: December 11, 2024

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Salveen Richter, Goldman Sachs lead U.S. biotech analyst, joins ‘Squawk on the Street’ to discuss Amgen’s mid-stage trial results for its experimental obesity drug, why she remains bullish on the company, where to invest in GLP-1 stocks, and more. Source link

Scott Chronert of Citi says Nvidia’s strong growth projections has made it ‘just another stock’. Source link

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Ron Heeks, Managing Director of Larvotto Resources, discusses how the company stands to benefit from China’s ban on rare earth exports and the importance of antimony. Source link

Entergy Corporation CEO Drew Marsh joins ‘Mad Money’ host Jim Cramer to discuss the company’s expanded long-term capital plan, its promising growth opportunities in the data center space, and more. ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Source link

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Venu Krishna, Barclays head of U.S. equity linked strategy, joins ‘Squawk on the Street’ to discuss what comes together in the next year, if Krishna’s sector playbook has changed, and much more. Source link

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Closing Bell Bruce Richards, Marathon Asset Management CEO, joins ‘Closing Bell’ to discuss the private credit, threats to the sector and growth trajectory. 05:00 11 minutes ago Source link